APA (7th ed.) Citation

Warmink, K., Rios, J. L., Varderidou-Minasian, S., Torres-Torrillas, M., van Valkengoed, D. R., Versteeg, S., . . . Lorenowicz, M. J. (2023). Mesenchymal stem/stromal cells-derived extracellular vesicles as a potentially more beneficial therapeutic strategy than MSC-based treatment in a mild metabolic osteoarthritis model. Stem Cell Research & Therapy, 14(1), 1. https://doi.org/10.1186/s13287-023-03368-7

Chicago Style (17th ed.) Citation

Warmink, Kelly, et al. "Mesenchymal Stem/stromal Cells-derived Extracellular Vesicles as a Potentially More Beneficial Therapeutic Strategy than MSC-based Treatment in a Mild Metabolic Osteoarthritis Model." Stem Cell Research & Therapy 14, no. 1 (2023): 1. https://doi.org/10.1186/s13287-023-03368-7.

MLA (9th ed.) Citation

Warmink, Kelly, et al. "Mesenchymal Stem/stromal Cells-derived Extracellular Vesicles as a Potentially More Beneficial Therapeutic Strategy than MSC-based Treatment in a Mild Metabolic Osteoarthritis Model." Stem Cell Research & Therapy, vol. 14, no. 1, 2023, p. 1, https://doi.org/10.1186/s13287-023-03368-7.